Cancers, Vol. 13, Pages 475: No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study

Added 485 days ago (26.01.2021)
Authors: Michele Guida; Nicola Bartolomeo; Pietro Quaglino; Gabriele Madonna; Jacopo Pigozzo; Anna Di Giacomo; Alessandro Minisini; Marco Tucci; Francesco Spagnolo; Marcella Occelli; Laura Ridolfi; Paola Queirolo; Ivana De Risi; Davide Quaresmini; Elisabetta Gambale; Vanna Chiaron Sileni; Paolo Ascierto; Lucia Stigliano; Sabino Strippoli; on behalf of the Italian Melanoma Intergroup (IMI) Study
Journal: Molecules
Read article